Motor Circuit Abnormalities in First-episode Schizophrenia Assessed with Transcranial Magnetic Stimulation

Abstract

Introduction: Abnormalities in corticosubcortical circuits in schizophrenia have been described by previous neuroimaging and electrophysiological studies. Previous studies assessing excitability of the motoneural system by measuring cortical silent period (CSP), short interval intracortical inhibition (SICI) and intracortical facilitation (ICF) with transcranial magnetic stimulation (TMS) revealed conflicting results.

Methods: We assessed resting motor threshold (RMT), SICI (interstimulus interval 3 milliseconds), ICF (interstimulus interval 7 milliseconds) and the duration of the contralateral CSP in the left and right first dorsal interosseus muscles (FDI) in 29 first-episode schizophrenia patients (FE-SZ) with limited exposure to antipsychotic treatment compared to 44 healthy control subjects (HC). CSP was measured during isometric contraction using stimulation intensities of 120, 140, 160 and 180% of RMT.

Results: Patients with FE-SZ demonstrated significant prolongation of CSP using stimulation intensities of 120% RMT (p=0.027), 140% RMT (p=0.015) and 160% RMT (p =0.010) of left motor cortex (right FDI) compared to HC. In addition, reduced SICI after stimulation of the right motor cortex was observed in FE-SZ (58.9% in FE-SZ vs. 31.4% in HC; p=0.050). RMT was similar in patients and controls.

Discussion: The reduced SICI in first-episode patients points towards a GABA_Aergic deficit in schizophrenia. The prolonged CSP may reflect compensatory increased GABA_Bergic transmission induced by hyperactivity of the dopaminergic system, although effects of antipsychotic medication could not be excluded.

References

• 1 Adler LE, Pachtman E, Frank RD. et al . Neuophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.  Biol. Psychiatry. 1982;  17 639-654
• 2 Annett M. A classification of hand preference by association analysis.  Br J Psychol. 1970;  61 303-321
• 3 Bajbouj M, Gallinat J, Niehaus L. et al . Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia.  Pharmacopsychiatry. 2004;  37 74-80
• 4 Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex.  Lancet. 1985;  1 1106-1107
• 5 Bassett AS, Collins EJ, Nuttall SE. et al . Positive and negative symptoms in families with schizophrenia.  Schizophr Res. 1993;  11 9-19
• 6 Beauregard M, Ferron A. Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an iontophoretic study.  Eur J Pharmacol. 1991;  205 225-231
• 7 Cantello R, Gianelli M, Civardi C. et al . Magnetic brain stimulation: the silent period after the motor evoked potential.  Neurology. 1992;  42 1951-1959
• 8 Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease.  Brain Res Brain Res Rev. 2002;  38 309-327
• 9 Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenia patients and their nonpsychotic siblings.  J Nerv Ment Dis. 2000;  188 84-89
• 10 Daskalakis ZJ, Christensen BK, Chen R. et al . Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation.  Arch Gen Psychiatry. 2002;  59 347-354
• 11 Daskalakis ZJ, Christensen BK, Chen R. et al . Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation.  Psychopharmacology (Berl). 2003;  170 255-262
• 12 Davey NJ, Puri BK, Lewis HS. et al . Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia.  J Neurol Neurosurg Psychiatry. 1997;  63 468-473
• 13 Day BL, Dressler D, Maertens De Noordhout A. et al . Electrical and magnetic stimulation of human motor cortex: surface EMG and single motor-unit responses.  J Physiol (Lond). 1989;  412 449-473
• 14 Di Lazarro V, Oliviero A, Profice P. et al . Ketamine increases human motor cortex excitability to transcranial magnetic stimulation.  J Physiol. 2003;  547 485-496
• 15 Endicott J, Spitzer RL, Fleiss JL. et al . The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance.  Arch Gen Psychiatry. 1976;  33 766-771
• 16 Fitzgerald PB, Brown TL, Daskalakis ZJ. et al . A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.  Psychopharmacology (Berl). 2002;  162 74-81
• 17 Fitzgerald PB, Brown TL, Daskalakis ZJ. et al . A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia.  Psychiatry Res. 2002;  114 11-22
• 18 Fitzgerald PB, Brown TL, Daskalakis ZJ. et al . A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation.  Schizophr Res. 2002;  56 199-209
• 19 Fitzgerald PB, Brown TL, Marston NA. et al . Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study.  Schizophr Res. 2004;  71 17-26
• 20 Freedman R, Adler LE, Waldo MC. et al . Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.  Biol Psychiatry. 1983;  18 537-551
• 21 Fydrich T, Renneberg B, Schmitz B. et al . Strukturiertes Klinisches Interview für DSM-IV. Achse II: Persönlichkeitsstörungen. A German, advanced adaptation of the original SCID version by RL. Spitzer, JB. Williams, M. Gibbon and MB. First. Göttingen: Hogrefe 1997
• 22 Guy W, Bonato RR. editors CGI: Clinical Global Impressions. In: Manual for the ECDEU Assessment Battery.2. Rev ed Md: National Institute of Mental Health: Chevy Chase 1976: p. 12/1-12/6
• 23 Hommel G. A comparison of two modified Bonferroni procedures.  Biometrika. 1988;  75 383-386
• 24 Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.  Schizophr Bull. 1987;  13 261-276
• 25 Langguth B, Eichhammer P, Spranz C. et al . Modulation of human motor cortex excitability by quetiapine.  Psychopharmacology. 2008;  196 623-629
• 26 Liepert J, Restemeyer C, Kucinski T. et al . Motor strokes: the lesion location determines motor excitability changes.  Stroke. 2005;  36 2648-2653
• 27 Maeda F, Pascual-Leone A. Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.  Psychopharmacology. 2003;  168 359-376
• 28 Moll GH, Heinrich H, Trott GE. et al . Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system.  Ann Neurol. 2001;  49 393-396
• 29 Puri BK, Davey NJ, Ellaway PH. et al . An investigation of motor function in schizophrenia using transcranial magneticstimulation of the motor cortex.  Br J Psychiatry. 1996;  169 690-695
• 30 Saka MC, Atbasoglu EC, Ozguven HD. et al . Cortical inhibition in first-degree relatives of schizophrenia patients assessed with transcranial magnetic stimulation.  Int J Neuropsychopharmacol. 2005;  7 1-5
• 31 Seeman P, Kapur S. Schizophrenia: more dopamine, more D2 receptors.  Proc Natl Acad Sci USA. 2000;  97 8104-8109
• 32 Simes RJ. An improved Bonferroni procedure for multiple tests of significance.  Biometrika. 1986;  73 751-754
• 33 Smith RC, Hussain MI, Chowdhury SA. et al . Stability of neurological soft signs in chronically hospitalised schizophrenia patients.  J Neuropsychiatry Clin Neurosci. 1999;  11 91-96
• 34 Vogels TP, Abbott LF. Gating deficits in model networks: a path to schizophrenia?.  Pharmacopsychiatry. 2007;  40 ((Suppl. 1)) S73-S77
• 35 Werhahn KJ, Kunesch E, Noachtar S. et al . Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.  J Physiol (Lond). 1999;  517 501-507
• 36 Winterer G. Prefrontal dopamine signalling in schizophrenia – the corticocentric model.  Pharmacopsychiatry. 2007;  40 ((Suppl 1)) S45-S53
• 37 Wittchen HU, Wunderlich U, Gruschwitz S. et al . Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. A German, advanced adaptation of the original SCID version by RL. Spitzer, JB. Williams, M. Gibbon and MB. First. Göttingen: Hogrefe 1997
• 38 Wobrock T, Kadovic D, Falkai P. Cortical excitability in schizophrenia.  Studies using transcranial magnetic stimulation. Nervenarzt. 2007;  78 753-754 756-763
• 39 Wobrock T, Schneider M, Kadovic D. et al . Reduced cortical inhibition in first-episode schizophrenia.  Schizophr Res. 2008;  , Jul 12 [Epub ahead of print]
• 40 Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics.  J Clin Psychiatry. 2003;  64 663-667
• 41 Ziemann U, Netz J, Szelenyi A. et al . Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex.  Neurosci Lett. 1993;  156 167-171
• 42 Ziemann U, Lonnecker S, Steinhoff BJ. et al . Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.  Ann Neurol. 1996;  40 367-378
• 43 Ziemann U, Tergau F, Bruns D. et al . Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.  Electroencephalogr Clin Neurophysiol. 1997;  105 430-437
• 44 Ziemann U. TMS and drugs.  Clin Neurophysiol. 2004;  115 1717-1729

Correspondence